Diurnal appoints Clinigen to launch a European Patient Access program for Infacort® and Chronocort® Infrastructure and supply chain now in place to provide Infacort® and Chronocort® as unlicensed medicines to patients on a Named Patient basis.

SEE PRESS RELEASE HERE.